MentalHealthDaily

Traumatic Injury and Depression Show Oxytocin Methylation Signal

by GLOOM

MHD featured image for traumatic injury, depression, and oxytocin-pathway methylation.

A 2026 Generation Scotland study linked traumatic physical injury to diagnosis-stratified blood methylation differences in 4,308 people.1 The clearest recurrent-depression signal pointed toward oxytocin signaling and synaptic-plasticity pathways, but the result is still exploratory pathway evidence rather than a blood test for depression or PTSD. Research Highlights Recurrent depression carried the strongest phenotype signal: traumatic …

COPE-A Reduced Youth PTSD in Substance-Use Trial

by GLOOM

MHD featured image for youth PTSD, substance use, COPE-A, and symptom sequencing during therapy.

A 2026 randomized youth trial found that integrated exposure-based treatment reduced posttraumatic stress disorder symptoms more than supportive counseling, while substance-use changes were smaller and showed no clear treatment-specific advantage. Research Highlights COPE-A reduced PTSD more: youth receiving Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure – Adolescent version had a 17.00-point …

PTSD Counterconditioning Strengthened fMRI Safety Memory

by GLOOM

A 2026 functional magnetic resonance imaging study involving 54 adults found that pairing a formerly threatening cue with positive images, a laboratory method called counterconditioning, strengthened later neural safety-memory signals in people with posttraumatic stress disorder. The experiment measured fear-learning biology, not PTSD symptom improvement after therapy.1 Research Highlights 54 adults were analyzed: Cooper et …

Low-Dose Oral THC Did Not Reduce Stress Memory Distress: 36-Adult Trier RCT

by GLOOM

Stylized Trier Social Stress Test memory scene with THC capsule and stress-response signals, representing a randomized trial showing no reduction in stress-memory distress.

Cannabis users often say the drug helps them blunt stressful memories. A 2026 randomized trial of 36 healthy adults tested low-dose oral THC against placebo during retrieval of a standardized lab stressor, and on every subjective and physiological measure that mattered, THC did nothing.1 Research Highlights 36-adult, 3-arm RCT: participants got placebo, 5 mg oral …

Major Upper-Extremity Amputation Raised Mental Health Odds

by GLOOM

Major upper-extremity amputation was linked to substantially higher odds of new mental-health diagnosis, antidepressant initiation, and psychotherapy claims than minor upper-extremity amputation in a matched national database study. The clearest clinical implication is early mental-health screening after major limb loss, not waiting for distress to surface months later.1 Research Highlights 2,452 matched patients were analyzed: …

Veteran Suicide Rates: 17.6 Daily, 73.5% by Firearm

by GLOOM

Editorial card showing the U.S. flag and silhouette of a service member, illustrating the 2024 VA national veteran suicide prevention annual report.

The most-quoted figure on veteran suicide is “22 a day,” produced from 21-state death-certificate data for 1999–2010.2 The VA’s 2024 Annual Report — with mortality data through 2022 — puts the current daily count at 17.6 Veteran suicides, but the per-Veteran rate has gone the other way.1 Research Highlights Daily count was 17.6: 6,407 Veteran …

Psychiatric Brain Biomarkers Lack Clinical Use: 441-Study Map

by GLOOM

Psychiatric brain biomarkers have produced a large research literature but little routine clinical use. A 2026 evidence map found 441 primary studies and 27 systematic reviews of neuroimaging or neurophysiologic biomarkers for mental-health disorders, yet the field still looks too small, cross-sectional, and depression-heavy for ordinary diagnostic or treatment decisions.1 Research Highlights Large map, weak …